Acadia Healthcare Co Raises FY2026 Adj EPS Guidance from $1.35-$1.60 to $2.55-$2.85 vs $1.51 Est; Raises FY2026 Sales Guidance from $3.370B-$3.450B to $3.900B-$4.200B vs $3.409B Est

Acadia Healthcare Co (NASDAQ:ACHC) raises FY2026 Adj EPS guidance from $1.35-$1.60 to $2.55-$2.85 vs $1.51 analyst estimate. Raises FY2026 sales outlook from $3.370 billion-$3.450 billion to $3.900 billion-$4.200 billion vs $3.409 billion estimate.